Precision BioSciences Inc (DTIL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $288.76M
Last updated: Nov 17, 2026 at 11:04 AM ET
Precision BioSciences Inc (DTIL) Earnings: Report Dates and Results
Precision BioSciences (DTIL) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Precision BioSciences reported EPS of -$0.65, above the -$1.02 estimate. It beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DTIL has an expected report date of Mar 10, 2027.
Earnings History
Of the 30 quarters below that had an estimate, DTIL beat 24 and missed 6. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 413.95% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.65 | -$1.02 | -$1.19 - -$0.63 | +36.27% | Beat | N/A | 3 | 1 up, 2 down | Nov 3, 2026 | N/A |
| Jun 30, 2026 | -$0.71 | -$0.74 | -$0.81 - -$0.57 | +4.05% | Beat | N/A | 3 | 0 up, 1 down | Aug 6, 2026 | N/A |
| Mar 31, 2026 | -$0.75 | -$0.81 | -$0.81 - -$0.81 | +7.41% | Beat | N/A | 1 | 0 up, 0 down | May 5, 2026 | $10.84M |
| Dec 31, 2025 | $1.01 | -$0.64 | -$1.10 - -$0.20 | +256.37% | Beat | N/A | 3 | 1 up, 0 down | Mar 12, 2026 | $34.20M |
| Sep 30, 2025 | -$1.84 | -$2.21 | -$2.21 - -$2.21 | +16.74% | Beat | N/A | 1 | 1 up, 0 down | Nov 3, 2025 | $13000 |
| Jun 30, 2025 | -$2.13 | -$0.09 | N/A | N/A | N/A | -145.6% | 2 | 1 up, 0 down | Aug 7, 2025 | $18000 |
| Mar 31, 2025 | -$2.21 | -$0.43 | N/A | -413.95% | Miss | -230.0% | 1 | 0 up, 0 down | May 15, 2025 | $29000 |
| Dec 31, 2024 | -$2.14 | -$2.95 | -$3.12 - -$2.77 | +27.47% | Beat | N/A | 2 | 1 up, 1 down | Mar 26, 2025 | $638000 |
| Sep 30, 2024 | -$2.25 | -$3.13 | -$3.27 - -$0.79 | +28.11% | Beat | N/A | 4 | 0 up, 0 down | Nov 4, 2024 | $576000 |
| Jun 30, 2024 | $4.67 | -$5.07 | N/A | +192.11% | Beat | N/A | 4 | 0 up, 0 down | Aug 1, 2024 | $49.90M |
| Mar 31, 2024 | $1.70 | -$1.91 | -$2.60 - -$0.45 | +189.01% | Beat | N/A | 6 | 0 up, 0 down | May 13, 2024 | $17.58M |
| Dec 31, 2023 | -$4.06 | -$2.05 | -$5.10 - $3.00 | -98.05% | Miss | N/A | 4 | 0 up, 0 down | Mar 27, 2024 | $7.04M |
| Sep 30, 2023 | -$2.10 | -$5.00 | -$6.61 - -$4.50 | +58.00% | Beat | N/A | 5 | 0 up, 0 down | Nov 7, 2023 | $13.12M |
| Jun 30, 2023 | -$3.00 | -$7.50 | -$8.11 - -$6.61 | +60.00% | Beat | N/A | 5 | 1 up, 0 down | Aug 4, 2023 | $19.79M |
| Mar 31, 2023 | -$6.55 | -$6.60 | N/A | +0.76% | Beat | N/A | 6 | 0 up, 0 down | May 9, 2023 | $8.78M |
| Dec 31, 2022 | -$0.26 | -$0.21 | -$0.26 - -$0.09 | -23.81% | Miss | N/A | 8 | 0 up, 0 down | Mar 9, 2023 | $10.60M |
| Sep 30, 2022 | -$6.60 | -$11.16 | -$14.41 - $11.11 | +40.86% | Beat | N/A | 8 | 0 up, 0 down | Nov 8, 2022 | $7.36M |
| Jun 30, 2022 | -$13.80 | -$13.92 | -$15.32 - -$8.41 | +0.86% | Beat | -227.8% | 9 | 0 up, 0 down | Aug 8, 2022 | $3.82M |
| Mar 31, 2022 | -$13.80 | -$16.20 | -$18.32 - -$11.41 | +14.81% | Beat | N/A | 9 | 0 up, 0 down | May 9, 2022 | $3.32M |
| Dec 31, 2021 | -$0.52 | -$0.47 | -$0.75 - -$0.22 | -10.64% | Miss | N/A | 10 | 0 up, 0 down | Mar 15, 2022 | $6.34M |
| Sep 30, 2021 | -$5.82 | -$17.71 | -$22.82 - -$11.71 | +67.14% | Beat | N/A | 9 | N/A | Nov 10, 2021 | $24.04M |
| Jun 30, 2021 | $10.80 | -$17.07 | -$20.72 - $7.21 | +163.27% | Beat | N/A | 9 | N/A | Aug 12, 2021 | $68.81M |
| Mar 31, 2021 | -$9.90 | -$16.47 | -$18.02 - -$9.31 | +39.89% | Beat | N/A | 9 | N/A | May 13, 2021 | $16.35M |
| Dec 31, 2020 | -$0.44 | -$0.11 | -$0.64 - $1.37 | -300.00% | Miss | N/A | 9 | N/A | Mar 18, 2021 | $8.85M |
| Sep 30, 2020 | -$15.00 | -$20.33 | -$25.83 - -$16.52 | +26.22% | Beat | N/A | 8 | N/A | Nov 10, 2020 | $7.36M |
| Jun 30, 2020 | -$18.90 | -$18.26 | -$20.72 - -$15.62 | -3.50% | Miss | N/A | 8 | N/A | Aug 13, 2020 | $1.08M |
| Mar 31, 2020 | -$15.60 | -$16.00 | -$18.92 - -$13.21 | +2.50% | Beat | N/A | 7 | N/A | May 15, 2020 | $7.00M |
| Dec 31, 2019 | -$0.36 | -$0.48 | -$0.72 - -$0.24 | +25.00% | Beat | N/A | 8 | N/A | Mar 10, 2020 | $6.52M |
| Sep 30, 2019 | -$12.30 | -$13.58 | -$22.52 - -$12.91 | +9.43% | Beat | N/A | 6 | N/A | Nov 12, 2019 | $4.87M |
| Jun 30, 2019 | -$9.89 | -$12.98 | -$21.92 - -$11.11 | +23.81% | Beat | N/A | 6 | N/A | Aug 14, 2019 | $5.39M |
| Mar 31, 2019 | -$11.40 | -$11.72 | -$13.21 - -$10.21 | +2.73% | Beat | N/A | 4 | N/A | Apr 29, 2019 | $5.46M |
| Dec 31, 2018 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 28, 2019 | $4.94M |
| Sep 30, 2018 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 19, 2018 | $2.54M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$5.17, after $1.98 the year before. It was -$0.15 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$5.17 | -360.8% |
| Dec 31, 2024 | $1.98 | N/A |
| Dec 31, 2023 | -$15.71 | N/A |
| Dec 31, 2022 | -$34.46 | N/A |
| Dec 31, 2021 | -$5.44 | N/A |
| Dec 31, 2020 | -$49.94 | N/A |
| Dec 31, 2019 | -$33.95 | N/A |
| Dec 31, 2018 | -$0.15 | N/A |
Frequently Asked Questions About DTIL
When is Precision BioSciences's next earnings date?
Precision BioSciences's next earnings report is expected for Mar 10, 2027.
Did DTIL beat earnings estimates last quarter?
Yes. Precision BioSciences reported EPS of -$0.65 for the quarter ended Sep 30, 2026, above the -$1.02 estimate, a 36.27% surprise.
What EPS do analysts expect from DTIL next quarter?
The consensus EPS estimate for Precision BioSciences for the quarter ending Dec 31, 2026 is -$0.83 from 7 analysts, with estimates from -$1.18 to -$0.58.
How often does DTIL beat earnings estimates?
Precision BioSciences beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate, with an average surprise of -4.69%.
DTIL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors